The Breast AI system brings hope and equity

The Breast AI system, a pioneering technology that revolutionises the early detection of breast cancer, is set to empower rural communities. We learn more about a case study of a breast health programme in South Africa.

You can listen to this article below, or by using your favourite podcast player at

In the heart of rural Acornhoek, Mpumalanga, a ground-breaking partnership between local healthcare providers, Medsol AI Solutions, Breast Health Foundation, Mpumalanga Department of Health and AstraZeneca’s A Catalyst Network has transformed the landscape of women’s health. 

Through a comprehensive breast health programme, communities once deprived of timely detection and treatment for breast cancer, now have access to state-of-the-art technology and vital education. This initiative not only exemplifies the power of collaboration but also underscores the importance of innovative solutions in addressing healthcare disparities.

At the core of this initiative lies the Breast AI system, a pioneering technology that revolutionises the early detection of breast cancer. Developed in partnership with Medsol AI and Clarius, this system utilises artificial intelligence to analyse breast ultrasound images during real-time imaging, offering precise and timely diagnosis. 

Coupled with health education workshops and training for local healthcare providers, the programme not only detects breast cancer at its nascent stage but also empowers communities with knowledge to promote proactive healthcare practices.

Equitable healthcare access

The impact of this initiative is profound, with a significant increase in access to timely breast cancer detection witnessed across multiple clinic sites in SA. By leveraging the power of clinical downstaging, the programme transcends the limitations of traditional screening methods, particularly in rural areas where resources are scarce. 

Clinical downstaging, as opposed to conventional screening, enables the detection of breast cancer at an earlier, more treatable stage, saving lives and reducing the burden on tertiary healthcare facilities.

The success of this model is evident in its replication across diverse healthcare sites, from bustling urban centres like Soweto to remote regions like Lufhereng and Clayville. 

With each implementation, the programme not only extends its reach but also reinforces the ethos 

of equitable healthcare access for all. By tailoring interventions to the specific needs of each community, the programme ensures that no one is left behind in the fight against breast cancer.

Tintswalo Hospital

One such testament to the programme’s efficacy is the recent integration of Tintswalo Hospital in Acornhoek. Despite facing challenges exacerbated by the COVID-19 pandemic, the hospital’s journey towards adopting the breast health programme signifies a beacon of hope for rural communities. The establishment of a dedicated breast clinic, coupled with on-site biopsy services, exemplifies the transformative impact of localised healthcare solutions.

Patients who attended the initial training week during the month of May, were able to receive on-site biopsies from the group of surgeons working at the Tintswalo Hospital, which typically would have been referred to other hospital sites two to six hours away from their home region.

The significance of this initiative extends beyond mere healthcare provision; it embodies a paradigm shift towards community-centric approaches to healthcare delivery. By fostering partnerships between stakeholders and harnessing cutting-edge technology, the programme not only saves lives but also empowers communities to take charge of their health.

Looking ahead, the journey towards comprehensive healthcare equity in SA continues. As the programme expands to new horizons, its legacy of empowerment and innovation serves as a beacon of hope for communities across the nation. Through collaboration, dedication, and a commitment to excellence, the battle against breast cancer marches forward, one community at a time.